found an abnormally high average urinary excretion of 1 7-ketosteroids in thirteen male patients with ankylosing spondylitis. In some cases, radiotherapy restored the excretion to normal. These results appeared worthy of further investigation. The urinary 1 7-ketosteroid excretion of a number of patients with ankylosing spondylitis and Sjogren's syndrome, in which rheumatoid manifestations are a common feature, has therefore been measured.
Experiments
Total neutral 17-ketosteroid estimations were carried out on 24-hr urine samples of eleven female patients with Sjogren's disease, and one female and five male patients with ankylosing spondylitis, all before treatment, or during an exacerbation of the disease. The method of analysis was similar to that recommended by the M.R.C. committee for clinical endocrinology. In three patients with Sjogren's syndrome and five with ankylosing spondylitis, the quantitative composition of the 17-ketosteroids was determined by separation into eight main fractions by adsorption chromatography (Pond, 1951) .
Results
The results of the total 17-ketosteroid assays are shown in Table I . The detailed results of the fractionation of the 17-ketosteroid extracts have been published elsewhere (Pond, 1953a) and summaries of the main findings are presented in Table II . All the total 1 7-ketosteroid estimations in patients with Sjogren's syndrome gave results of between I and 3 mg./24 hrs (average 2 3 mg., i.e. below the lower limit of normal for women for this laboratory) (see Table I ). In contrast, the results in the patients with ankylosing spondylitis were all within normal limits. None approached the upper limit of the normal range as suggested by the work of Davison and others (1947) , but on the contrary, some approached the lower limit of normality.
Fractionation of the 1 7-ketosteroid extracts showed the following trends in steroid excretion in these two types of patient:
The patients with Sjogren's disease showed a lowering of all fractions and in particular a lowering of the 3 fraction, which is generally considered to be an indication of adrenocortical activity.
The I I-oxy-17-ketosteroid fraction (a probable breakdown product of the adrenal glucocorticoids) was rather low in one patient, but within normal limits in the other two.
One patient showed a relatively raised etiocholanolone excretion, which has been found by other workers to be characteristic of patients with debilitating or malignant disease (Robinson and Goulden, 1949) . Etiocholanolone is a non-androgenic isomer of androsterone, and the two fractions normally constitute two-thirds of the total 1 7-ketosteroids. A rise of this fraction is not necessarily of endocrinological significance.
The fractionation patterns of patients with ankylosing spondylitis were within normal limits with few exceptions: one patient showed an unusually high P fraction, for which no apparent explanation could be found; one showed a high value for etiocholanolone, probably suggestive of general debility as previously described; only one showed any significant lowering of the I 1-oxy-17-ketosteroid fraction, though all were below the mean for normal men.
Discussion
It is interesting that the excretion of 1 7-ketosteroids was consistently lowered in all patients with Sj6gren's disease. The only other case of Sj6gren's disease, in which 1 7-ketosteroid assay has been recorded in the literature, had a normal value (Frenkel, Hellinga, and Groen, 1951) . The low values here may, in part, be due to the advanced ages of these patients, though three of them were under 50 years (36-71 years, average 54). It is also possible that the difficulties of mastication experienced by many of them, may lead to under-nourishment, which will in itself lower 17-ketosteroid excretion. Fractionation studies failed to throw much light on the cause of the low 17-ketosteroid values. The 11-oxy-17-ketosteroids, which are probably metabolic end-products of the adrenal cortical hormone functions, were mainly within normal limits. The low 3 fraction suggested a deficiency in the production of other important steroids of the adrenal cortex. The significance of the excretion of these various steroids is more fully discussed elsewhere (Pond, 1954 ). The conclusion is that the results of 17-ketosteroid studies do not indicate any endocrine abnormality in Sj6gren's disease; they reflect the debilitating nature of the disease, but suggest a potentially normal adrenocortical function.
The results of Davison and others (1947) in ankylosing spondylitis cannot be confirmed. Three of those cases were complicated by other conditions, anaemia, pulmonary tuberculosis, and muscular dystrophy, which might lower the 17-ketosteroid output, but no explanation can be offered for the consistent failure to find high values. Fractionation of the 1 7-ketosteroids showed no abnormality of the type of steroid excreted with the exception of one rather high 3 fraction. No explanation can be offered for this, but it has also been found occasionally in normal men. One patient showed changes reflecting the debilitating nature of the disease, as in Sjogren's patients. Again, there is no suggestion that these patients have any endocrine abnormality of androgen function, although adrenocortical activity as represented by excretion of the 11-3-hydroxy 17-ketosteroids seems to be slightly below the average. This may be associated with a low adrenal corticoid excretion, which is interesting, since these patients often respond well to cortisone. 
